Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2006
[Anaemia and prostatic cancer]Rania Boustany, Marc Zerbib
Case Reports in Oncology|November 1, 2021
Paraneoplastic Cushing Syndrome in Gastrointestinal Neuroendocrine TumourLaurent Mineur, Rania Boustany, Léa Vazquez
Annales D'Urologie|November 24, 2005
[GnRH analogs and prostate cancer treatment]Marc Zerbib
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Treatments in invasive bladder cancer]Olivier Bouchot, Marc Zerbib
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2004
[Review of the value of BCG maintenance therapy in superficial bladder tumours]Michaël Peyromaure, Marc Zerbib
Cancers|April 13, 2023
Retrospective Analysis of a Cohort of Patients with Metastatic Bladder Cancer with Metastatic Sites Limited to the Pelvis and Retroperitoneum Treated at a Single Institution between 2009 and 2020Alexandre Bertucci, Lysian Cartier, Armelle Rollet, et al.
Bulletin Du Cancer|August 22, 2022
[Cancers induced by occupational exposure: What progress has been made?]Benoit Delabrusse, Brigitte Le Meur, Léa Vazquez, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
Capecitabine/Mitomycin versus 5-Fluorouracil/Mitomycin in Combination with Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Anal CancerLaurent Mineur, Léa Vazquez, Mohamed Belkacemi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2002
[Nadir PSA and kinetics of PSA decline between the 3rd and 6th month after external beam radiotherapy for T1 T2 Nx M0 localized prostate cancer: value of the prediction of the risk of biological progression]Christophe Almeras, Marc Zerbib, François Eschwege, et al.
Bulletin Du Cancer|April 21, 2012
[Management of metastatic castration-resistant prostate cancer following docetaxel]Philippe Beuzeboc, Stanislas Ropert, François Goldwasser, et al.
Pageof 11